Bullous pemphigoid, an immune-mediated condition characterized by large, fluid-filled blisters on the skin, is a rare but serious complication of cancer therapy with immune checkpoint inhibitors (ICIs ...

Pronounced “BULL-us PEM-fih-goyd” (with bullous being the medical term for a large blister), Bullous Pemphigoid is a rare, autoimmune, chronic skin disorder that causes large, fluid-filled blisters.

DEAR DR. ROACH: I have had an autoimmune disease called bullous pemphigoid for the past four years. I originally was treated with prednisone therapy for over a year, which was then tapered and changed ...

More patients treated with dupilumab experienced sustained disease remission and itch reduction at week 36 compared with those who received placebo. The Food and Drug Administration (FDA) has approved ...

A Prescription Drug User Fee Act target date of June 20, 2025 has been set for the application. The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics ...

Autoimmune bullous disorders constitute a group of rare but potentially life‐threatening dermatological conditions marked by the production of pathogenic autoantibodies directed against structural ...

This data may bring patients with the rare immunobullous disease closer to an eventual FDA-approved treatment. Rituximab (RTX) and omalizumab (OMZ) combination treatment may be well-tolerated and ...

Please provide your email address to receive an email when new articles are posted on . Researchers identified three different clusters of bullous pemphigoid, the most common autoimmune blistering ...

Anti-BP180 antibody levels demonstrated a moderate to strong correlation with the severity of bullous pemphigoid (BP), in a meta-analysis highlighting the potential of anti-BP180 as a tool to monitor ...

Please provide your email address to receive an email when new articles are posted on . Steroid alternatives should be considered for patients with bullous pemphigoid, who are most likely to be ...